About vaccines

Infection does offer some immune protection—but it's unreliable compared with vaccines. // 8.10.2021

Researchers from Roche Diagnostics have been testing a new assay known as the Elecsys assay. // 8.10.2021

Researchers from the U.S. Veterans Affairs have examined the U.S. effort to vaccinate its Veteran population to investigate further. // 8.10.2021

A new preprint discusses the protective effect of an oral adenovirus-vectored vaccine based on the SARS-CoV-2 spike against viral transmission and disease in hamsters. // 8.10.2021

The rollout of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is expanding worldwide. However, little is known about the duration of protection offered by these vaccines. Real-world data on the kinetics of antibodies are beginning to appear, but a holistic picture of immunity duration is still not available. // 7.102021

A study identified associations between COVID-19 infections, hospitalizations, and deaths among Medicare FFS beneficiaries and the fully vaccinated population at the county level. // 7.10.2021

People need to know this. //7.10.2021

// 7.10.2021

https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.121.056135 // 10.8.2021

The study "Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study" is published in the journal The Lancet. // 7.10.2021

A recent study presents evidence that a booster dose of the Moderna vaccine can induce a robust memory immune response against COVID-19. // 6.10.2021

Nuorille miehille ei suositella kolmatta rokoteannosta. // 6.10.2021

Now, a new study published in the journal JAMA Internal Medicine evaluated the incidence of acute myocarditis and clinical outcomes among adults who received the mRNA vaccine in an integrated health care system in the United States. // 6.10.2021

These gains, however, could be swiftly reversed by the Delta variant, which has the potential to unleash a surge of new cases among people who are unvaccinated. // 8.7.2021

Researchers from the University of Singapore have reviewed the data in post-vaccinated immunocompromised patients to examine the effectiveness of these vaccines in these patients. // 5.10.2021

Researchers from the US recently characterized the scale and specificity of SARS-CoV-2 spike-reactive antibodies from 23 participants who received SARS-CoV-2 mRNA vaccines and 10 acutely infected health care workers. // 5.10.2021

Researchers in the United States have demonstrated the real-world effectiveness of Moderna’s mRNA-1273 vaccine at protecting against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and preventing hospitalization due to coronavirus disease 2019 (COVID-19). // 4.10.2021

Researchers investigate the effects of five established immunosuppressant medications following COVID-19 vaccination. // 4.10.2021

In a recent study, researchers performed bulk RNA-Seq transcriptomic profiling of lungs from vaccinated and unvaccinated hamsters with the Janssen vaccine. // 4.10.2021

A recent study assesses the serological and cellular responses to Pfizer’s BNT162b2 mRNA vaccine in people aged 80-96 years. // 4.10.2021

In a recent study, researchers analyzed antibody responses to the homologous Wu strain and several other SARS-CoV-2 variants after BNT162b2 vaccination. // 4.10.2021

The findings reveal that patients infected with alpha, beta, gamma, and delta variants have a higher risk of hospitalization than those infected with the original viral strain that emerged in Wuhan, China, in late December 2019. // 4.10.2021

Reports of vaccines’ decline have been greatly overstated. // 3.10.2021

Suomalainen nenäsumutetta kehittävä Rokote Laboratories etenee vaiheittain testien rahoittamisessa. Uusi ankkurisijoittaja ja toimitusjohtaja lisäävät toivoa myös loppurahoituksen löytämisestä. // 1.10.2021

Barney Graham prepared the world for this pandemic, and the scientists he mentored will prepare us for the next one. // 1.10.2021

Biontechin toimitusjohtaja Ugur Sahin arvioi Financial Timesille (FT), että muokattua koronavirusrokotetta tarvittanee ensi vuoden puoliväliin mennessä. // 3.10.2021

Rokotehaittoja ei salata eikä niitä peitellä, vakuuttaa Fimea. // 3.10.2021

Researchers from the University of Oxford have been examining the impact of vaccination on the spread of the Alpha and Delta variants through the population. // 1.10.2021

Here's what experts know so far about the timeframe for spreading the virus. // 30.9.2021

Is one COVID vaccine better than the other? Four current vaccines — Moderna, Pfizer-BioNTech, Johnson & Johnson, and AstraZeneca — are highly effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but a new medRxiv* study suggests the level of protection varies. // 30.9.2021